<div class="embed-responsive embed-responsive-16by9"><iframe width="640" height="360" style="max-width: 100%;max-height: 100%; border:none;" src="https://oncologytube.com/videoEmbed/28852/treatment-of-1st-line-rcc-selection-of-i-o-and-tkis?channelName=obr&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" frameborder="0" allowfullscreen="allowfullscreen" allow="autoplay" scrolling="no">iFrame is not supported!</iframe></div>

Treatment of 1st Line RCC selection of I-O and TKIs

Name: Treatment of 1st Line RCC selection of I-O and TKIs
Uploaded: 2019-06-25T08:11:54
Duration: 1 min 14 s
Description: Michael B. Atkins MD at Georgetown Lombardi Comprehensive Cancer Center, Scholl Professor and Vice Chair Department of Oncology discusses how to select between different combinations of immuno-oncology and TKIs that are available and for the treatment of 1st line renal cell carcinoma (RCC).

00:01:14

Don

3 years 89 Views

Share Add to Report 0 0

Embed (Iframe):

<div class="embed-responsive embed-responsive-16by9"><iframe width="640" height="360" style="max-width: 100%;max-height: 100%; border:none;" src="https://oncologytube.com/videoEmbed/28852/treatment-of-1st-line-rcc-selection-of-i-o-and-tkis?channelName=obr&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" frameborder="0" allowfullscreen="allowfullscreen" allow="autoplay" scrolling="no">iFrame is not supported!</iframe></div>

Embed (Object):

<div class="embed-responsive embed-responsive-16by9"><object width="640" height="360"><param name="movie" value="https://oncologytube.com/videoEmbed/28852/treatment-of-1st-line-rcc-selection-of-i-o-and-tkis?channelName=obr&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit="></param><param name="allowFullScreen" value="true"></param><param name="allowscriptaccess" value="always"></param><embed src="https://oncologytube.com/videoEmbed/28852/treatment-of-1st-line-rcc-selection-of-i-o-and-tkis?channelName=obr&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" allowscriptaccess="always" allowfullscreen="true" width="640" height="360"></embed></object></div>

Link (HTML):

<a href="https://oncologytube.com/v/28852?channelName=obr"><img src="https://oncologytubecom.cdn.ypt.me/videos/video_190625201154_cdfd/video_190625201154_cdfd.jpg?cache=15669161741678829655">Treatment of 1st Line RCC selection of I-O and TKIs</a>

Link (BBCode):

[url=https://oncologytube.com/v/28852?channelName=obr][img]https://oncologytubecom.cdn.ypt.me/videos/video_190625201154_cdfd/video_190625201154_cdfd.jpg?cache=15669161741678829655[/img]Treatment of 1st Line RCC selection of I-O and TKIs[/url]

Sign in now!

Permanent Link

URL Friendly (SEO)

Current Time (SEO)

Category:

Immunotherapy

Description:

Michael B. Atkins MD at Georgetown Lombardi Comprehensive Cancer Center, Scholl Professor and Vice Chair Department of Oncology discusses how to select between different combinations of immuno-oncology and TKIs that are available and for the treatment of 1st line renal cell carcinoma (RCC).